Citations (100)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Kandasamy Saravanan, Govindasamy Hunday & Poomani Kumaradhas. (2020) Binding and stability of indirubin-3-monoxime in the GSK3β enzyme: a molecular dynamics simulation and binding free energy study. Journal of Biomolecular Structure and Dynamics 38:4, pages 957-974.
Read now
Read now
Juan F. González, Andrés R. Alcántara, Antonio L. Doadrio & Jose María Sánchez-Montero. (2019) Developments with multi-target drugs for Alzheimer’s disease: an overview of the current discovery approaches. Expert Opinion on Drug Discovery 14:9, pages 879-891.
Read now
Read now
Behzad Varamini, Angelos K. Sikalidis & Kathryn L. Bradford. (2014) Resveratrol increases cerebral glycogen synthase kinase phosphorylation as well as protein levels of drebrin and transthyretin in mice: an exploratory study. International Journal of Food Sciences and Nutrition 65:1, pages 89-96.
Read now
Read now
Articles from other publishers (97)
Mahammad Ghouse Shaik, Swanand Vinayak Joshi, Ravikumar Akunuri, Preeti Rana, Ziaur Rahman, Anusha Polomoni, Venkata Madhavi Yaddanapudi, Manoj P. Dandekar & Nanduri Srinivas. (2023) Small molecule inhibitors of NLRP3 inflammasome and GSK-3β in the management of traumatic brain injury: A review. European Journal of Medicinal Chemistry 259, pages 115718.
Crossref
Crossref
Yue-ran Jia, Zi-qing Guo, Qian Guo & Xiao-chuan Wang. (2023) Glycogen Synthase Kinase-3β, NLRP3 Inflammasome, and Alzheimer’s Disease. Current Medical Science 43:5, pages 847-854.
Crossref
Crossref
Richard A. Hartz, Vijay T. Ahuja, Guanglin Luo, Ling Chen, Prasanna Sivaprakasam, Hong Xiao, Carol M. Krause, Wendy J. Clarke, Songmei Xu, John S. Tokarski, Kevin Kish, Hal Lewis, Nicolas Szapiel, Ramu Ravirala, Sayali Mutalik, Deepa Nakmode, Devang Shah, Catherine R. Burton, John E. Macor & Gene M. Dubowchik. (2023) Discovery of 2-(Anilino)pyrimidine-4-carboxamides as Highly Potent, Selective, and Orally Active Glycogen Synthase Kinase-3 (GSK-3) Inhibitors. Journal of Medicinal Chemistry 66:11, pages 7534-7552.
Crossref
Crossref
Bo Pang, Lu-Lu Zhang, Bin Li, Feng-Xian Sun & Zhi-Da Wang. (2023) The sodium glucose co-transporter 2 inhibitor ertugliflozin for Alzheimer's disease: Inhibition of brain insulin signaling disruption-induced tau hyperphosphorylation. Physiology & Behavior 263, pages 114134.
Crossref
Crossref
Richard A. Hartz, Vijay T. Ahuja, Prasanna Sivaprakasam, Hong Xiao, Carol M. Krause, Wendy J. Clarke, Kevin Kish, Hal Lewis, Nicolas Szapiel, Ramu Ravirala, Sayali Mutalik, Deepa Nakmode, Devang Shah, Catherine R. Burton, John E. Macor & Gene M. Dubowchik. (2023)
Design, Structure–Activity Relationships, and In Vivo Evaluation of Potent and Brain-Penetrant Imidazo[1,2-
b
]pyridazines as Glycogen Synthase Kinase-3β (GSK-3β) Inhibitors
. Journal of Medicinal Chemistry 66:6, pages 4231-4252.
Crossref
Crossref
Danny Baltissen, Charlotte S. Bold, Lena Rehra, Marija Banićević, Justus Fricke, Jennifer Just, Susann Ludewig, Christian J. Buchholz, Martin Korte & Ulrike C. Müller. (2023) APPsα rescues CDK5 and GSK3β dysregulation and restores normal spine density in Tau transgenic mice. Frontiers in Cellular Neuroscience 17.
Crossref
Crossref
Heather M. Stein, Surendra R. Gundam, Aditya Bansal, Nicholas R. Nelson, Geoffry L. Curran, Timothy R. DeGrado, Mark A. Frye, John D. Port, Val J. Lowe, Melissa E. Murray & Mukesh K. Pandey. (2022)
Comparison of [
18
F]F‐CNBI and [
18
F]F‐CNPIFE as Positron Emission Tomography Probes for Noninvasive Imaging of Glycogen Synthase Kinase‐3 in Normal Mice
. European Journal of Organic Chemistry 26:3.
Crossref
Crossref
Anil Gupta. (2022) Role of Glycogen Synthase Kinase 3 in Molecular Pathology of Alzheimer’s Disease. International Journal of Health Sciences and Pharmacy, pages 181-199.
Crossref
Crossref
I. O. Zakharova, L. V. Bayunova, K. V. Derkach, I. O. Ilyasov, I. Yu. Morina, A. O. Shpakov & N. F. Avrova. (2022) Effects of Intranasally Administered Insulin and Gangliosides on Hypothalamic Signaling and Expression of Hepatic Gluconeogenesis Genes in Rats with Type 2 Diabetes Mellitus. Journal of Evolutionary Biochemistry and Physiology 58:6, pages 1744-1765.
Crossref
Crossref
James J. Yang. (2022) Brain insulin resistance and the therapeutic value of insulin and insulin-sensitizing drugs in Alzheimer’s disease neuropathology. Acta Neurologica Belgica 122:5, pages 1135-1142.
Crossref
Crossref
Reza Majidazar, Erfan Rezazadeh-Gavgani, Saeed Sadigh-Eteghad & Amirreza Naseri. (2022) Pharmacotherapy of Alzheimer’s disease: an overview of systematic reviews. European Journal of Clinical Pharmacology 78:10, pages 1567-1587.
Crossref
Crossref
Nahed S. Alharthi, Fahad M. Aldakheel & Abdulkarim S. Binshaya. (2022) Inhibition of Glycogen Synthase Kinase and the Neuroprotective Function of Conjugated ZnO-Osthol Nanoparticles in Alzheimer’s Disease. Bioinorganic Chemistry and Applications 2022, pages 1-9.
Crossref
Crossref
Mokhamad Fahmi Rizki SyabanRislan Faiz MuhammadBasyar AdnaniGumilar Fardhani Ami PutraNabila Erina ErwanSafira Dita ArvianaAgung Dwi KrisnayanaDedy Budi Kurniawan. (2022) Molecular Docking Studies of Interaction Curcumin against Beta-secretase 1, Amyloid A4 Protein, Gamma-secretase and Glycogen Synthase Kinase-3β as Target Therapy for Alzheimer Disease. Research Journal of Pharmacy and Technology, pages 3069-3074.
Crossref
Crossref
Suélen Santos Alves, Rui Milton Patrício da Silva Junior, Polianna Delfino-Pereira, Marilia Gabriella Alves Goulart Pereira, Israel Vasconcelos, Hanna Schwaemmle, Rodrigo Focosi Mazzei, Maiko Luiz Carlos, Enilza Maria Espreafico, Antônio Claudio Tedesco, Adriano Sebollela, Sebastião Sousa Almeida, José Antônio Cortes de Oliveira & Norberto Garcia-Cairasco. (2022) A Genetic Model of Epilepsy with a Partial Alzheimer’s Disease-Like Phenotype and Central Insulin Resistance. Molecular Neurobiology 59:6, pages 3721-3737.
Crossref
Crossref
Enrique Blázquez, Verónica Hurtado-Carneiro, Yannick LeBaut-Ayuso, Esther Velázquez, Luis García-García, Francisca Gómez-Oliver, Juan Miguel Ruiz-Albusac, Jesús Ávila & Miguel Ángel Pozo. (2022) Significance of Brain Glucose Hypometabolism, Altered Insulin Signal Transduction, and Insulin Resistance in Several Neurological Diseases. Frontiers in Endocrinology 13.
Crossref
Crossref
Taha F. S. Ali, Halil I. Ciftci, Mohamed O. Radwan, Eslam Roshdy, Ahmed M. Shawky, Mohammed A. S. Abourehab, Hiroshi Tateishi, Masami Otsuka & Mikako Fujita. (2022) Discovery of Azaindolin-2-One as a Dual Inhibitor of GSK3β and Tau Aggregation with Potential Neuroprotective Activity. Pharmaceuticals 15:4, pages 426.
Crossref
Crossref
Athanasia Athanasaki, Konstantinos Melanis, Ioanna Tsantzali, Maria Ioanna Stefanou, Sofia Ntymenou, Sotirios G. Paraskevas, Theodosis Kalamatianos, Eleni Boutati, Vaia Lambadiari, Konstantinos I. Voumvourakis, George Stranjalis, Sotirios Giannopoulos, Georgios Tsivgoulis & George P. Paraskevas. (2022) Type 2 Diabetes Mellitus as a Risk Factor for Alzheimer’s Disease: Review and Meta-Analysis. Biomedicines 10:4, pages 778.
Crossref
Crossref
Amit Kumar Lalwani, Kushagra Krishnan, Sali Abubaker Bagabir, Mustfa F. Alkhanani, Atiah H. Almalki, Shafiul Haque, Saurabh Kumar Sharma, R. K. Brojen Singh & Md. Zubbair Malik. (2022) Network Theoretical Approach to Explore Factors Affecting Signal Propagation and Stability in Dementia’s Protein-Protein Interaction Network. Biomolecules 12:3, pages 451.
Crossref
Crossref
Shan He, Wei-Bing Peng, Xian-Jun Fu, Hong-Lei Zhou & Zhen-Guo Wang. (2022) Deep Sea Water Alleviates Tau Phosphorylation and Cognitive Impairment via PI3K/Akt/GSK-3β Pathway. Marine Biotechnology 24:1, pages 68-81.
Crossref
Crossref
A Young Sim, Sumit Barua, Jong Youl Kim, Yong-ho Lee & Jong Eun Lee. (2021) Role of DPP-4 and SGLT2 Inhibitors Connected to Alzheimer Disease in Type 2 Diabetes Mellitus. Frontiers in Neuroscience 15.
Crossref
Crossref
Santosh R. D’Mello. (2021) When Good Kinases Go Rogue: GSK3, p38 MAPK and CDKs as Therapeutic Targets for Alzheimer’s and Huntington’s Disease. International Journal of Molecular Sciences 22:11, pages 5911.
Crossref
Crossref
Jiahuan Hao, Yan Tang, Xinghua Liu & Ensheng Yao. (2021) Inhibiting PI3K leads to glucose metabolism disturbance in default mode network. Brain Research Bulletin 170, pages 218-224.
Crossref
Crossref
Yuhua Zhong, Shaoxi Yang, Jianyu Cui, Jie Wang, Lin Li, Yilin Chen, Junjie Chen, Pengju Feng, Shun Huang, Hongsheng Li, Yanjian Han, Ganghua Tang & Kongzhen Hu. (2021)
Novel
18
F-Labeled Isonicotinamide-Based Radioligands for Positron Emission Tomography Imaging of Glycogen Synthase Kinase-3β
. Molecular Pharmaceutics 18:3, pages 1277-1284.
Crossref
Crossref
Audrey Hector & Jonathan Brouillette. (2021) Hyperactivity Induced by Soluble Amyloid-β Oligomers in the Early Stages of Alzheimer's Disease. Frontiers in Molecular Neuroscience 13.
Crossref
Crossref
Xueyang Jiang, Yang Wang, Chang Liu, Caiyi Xing, Yingming Wang, Weiping Lyu, Saisai Wang, Qihang Li, Tingkai Chen, Yao Chen, Feng Feng, Wenyuan Liu & Haopeng Sun. (2021) Discovery of potent glycogen synthase kinase 3/cholinesterase inhibitors with neuroprotection as potential therapeutic agent for Alzheimer’s disease. Bioorganic & Medicinal Chemistry 30, pages 115940.
Crossref
Crossref
Vishal Kumar VishwakarmaTarique Mahmood Ansari, Anup Maiti, Ritesh Kumar Srivastav, Paramdeep Bagga & Farogh Ahsan. (2020) INTRUSION OF GLYCOGEN SYNTHASE KINASE-3Β TO COPE VARIOUS CARDIAC DISORDERS AT MOLECULAR LEVEL. INDIAN DRUGS 57:09, pages 7-18.
Crossref
Crossref
Michael Shaughness, Deanna Acs, Fiona Brabazon, Nicole Hockenbury & Kimberly R. Byrnes. (2020) Role of Insulin in Neurotrauma and Neurodegeneration: A Review. Frontiers in Neuroscience 14.
Crossref
Crossref
Jinwang Ye, Ying Yin, Yaling Yin, Huaqiu Zhang, Huali Wan, Lu Wang, Yue Zuo, Di Gao, Mengzhu Li, Jun Li, Yanchao Liu, Dan Ke & Jian‐Zhi Wang. (2020) Tau‐induced upregulation of C/EBPβ‐TRPC1‐SOCE signaling aggravates tauopathies: A vicious cycle in Alzheimer neurodegeneration. Aging Cell 19:9.
Crossref
Crossref
Agnieszka Zagórska & Anna Jaromin. (2020) Perspectives for New and More Efficient Multifunctional Ligands for Alzheimer′s Disease Therapy. Molecules 25:15, pages 3337.
Crossref
Crossref
Samuele Maramai, Mohamed Benchekroun, Moustafa T. Gabr & Samir Yahiaoui. (2020) Multitarget Therapeutic Strategies for Alzheimer’s Disease: Review on Emerging Target Combinations. BioMed Research International 2020, pages 1-27.
Crossref
Crossref
Santosh R D’Mello. (2020) Histone deacetylase-3: Friend and foe of the brain. Experimental Biology and Medicine 245:13, pages 1130-1141.
Crossref
Crossref
Runxuan Lin, Nigel Charles Jones & Patrick Kwan. (2020) Unravelling the Role of Glycogen Synthase Kinase-3 in Alzheimer’s Disease-Related Epileptic Seizures. International Journal of Molecular Sciences 21:10, pages 3676.
Crossref
Crossref
Yasumasa Ohyagi & Satoko I. Takei. (2020) Insulin signaling as a therapeutic target in Alzheimer’s disease: Efficacy of apomorphine. Neurology and Clinical Neuroscience 8:3, pages 146-154.
Crossref
Crossref
Jiayang Xie, Ruirui Liang, Yajiang Wang, Junyi Huang, Xin Cao & Bing Niu. (2020) Progress in Target Drug Molecules for Alzheimer's Disease. Current Topics in Medicinal Chemistry 20:1, pages 4-36.
Crossref
Crossref
Alexey A. Lagunin, Sergey M. Ivanov, Tatyana A. Gloriozova, Pavel V. Pogodin, Dmitry A. Filimonov, Sandeep Kumar & Rajesh K. Goel. (2020) Combined network pharmacology and virtual reverse pharmacology approaches for identification of potential targets to treat vascular dementia. Scientific Reports 10:1.
Crossref
Crossref
Santosh Jadhav, Jesus Avila, Michael Schöll, Gabor G. Kovacs, Enikö Kövari, Rostislav Skrabana, Lewis D Evans, Eva Kontsekova, Barbara Malawska, Rohan de Silva, Luc Buee & Norbert Zilka. (2019) A walk through tau therapeutic strategies. Acta Neuropathologica Communications 7:1.
Crossref
Crossref
Viktoriya Ivasiv, Claudia Albertini, Ana E. Gonçalves, Michele Rossi & Maria L. Bolognesi. (2019) Molecular Hybridization as a Tool for Designing Multitarget Drug Candidates for Complex Diseases. Current Topics in Medicinal Chemistry 19:19, pages 1694-1711.
Crossref
Crossref
Yam Nath Paudel, Efthalia Angelopoulou, Nigel C. Jones, Terence J. O’Brien, Patrick Kwan, Christina Piperi, Iekhsan Othman & Mohd. Farooq Shaikh. (2019) Tau Related Pathways as a Connecting Link between Epilepsy and Alzheimer’s Disease. ACS Chemical Neuroscience 10:10, pages 4199-4212.
Crossref
Crossref
Pengfei Zhang, Shengtao Xu, Zheying Zhu & Jinyi Xu. (2019) Multi-target design strategies for the improved treatment of Alzheimer's disease. European Journal of Medicinal Chemistry 176, pages 228-247.
Crossref
Crossref
Michelle L. Garcez, Kelly R. Jacobs & Gilles J. Guillemin. (2019) Microbiota Alterations in Alzheimer’s Disease: Involvement of the Kynurenine Pathway and Inflammation. Neurotoxicity Research 36:2, pages 424-436.
Crossref
Crossref
Jahangir Alam & Lalit Sharma. (2019) Potential Enzymatic Targets in Alzheimer’s: A Comprehensive Review. Current Drug Targets 20:3, pages 316-339.
Crossref
Crossref
Yingjia Yao, Yameng Wang, Liang Kong, Yuqing Chen & Jingxian Yang. (2019) Osthole decreases tau protein phosphorylation via PI3K/AKT/GSK-3β signaling pathway in Alzheimer's disease. Life Sciences 217, pages 16-24.
Crossref
Crossref
Yasumasa Ohyagi, Katsue Miyoshi & Norimichi Nakamura. 2019. Diabetes Mellitus. Diabetes Mellitus
227
248
.
Qi Li, Siyu He, Yao Chen, Feng Feng, Wei Qu & Haopeng Sun. (2018) Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease. European Journal of Medicinal Chemistry 158, pages 463-477.
Crossref
Crossref
Annachiara Gandini, Manuela Bartolini, Daniele Tedesco, Loreto Martinez-Gonzalez, Carlos Roca, Nuria E. Campillo, Josefa Zaldivar-Diez, Concepción Perez, Giampaolo Zuccheri, Andrea Miti, Alessandra Feoli, Sabrina Castellano, Sabrina Petralla, Barbara Monti, Martina Rossi, Fabio Moda, Giuseppe Legname, Ana Martinez & Maria Laura Bolognesi. (2018) Tau-Centric Multitarget Approach for Alzheimer’s Disease: Development of First-in-Class Dual Glycogen Synthase Kinase 3β and Tau-Aggregation Inhibitors. Journal of Medicinal Chemistry 61:17, pages 7640-7656.
Crossref
Crossref
Chan-Chuan Liu, Pei-Chuan Ho, I.-Ting Lee, Yu-An Chen, Chun-Hsien Chu, Chih-Chuan Teng, Sheng-Nan Wu, Chun-I. Sze, Ming-Fu Chiang & Nan-Shan Chang. (2018) WWOX Phosphorylation, Signaling, and Role in Neurodegeneration. Frontiers in Neuroscience 12.
Crossref
Crossref
Ratan V. Bhat, Ulf Andersson, Shalini Andersson, Laurent Knerr, Udo Bauer & Anna K. Sundgren-Andersson. (2018) The Conundrum of GSK3 Inhibitors: Is it the Dawn of a New Beginning?. Journal of Alzheimer's Disease 64:s1, pages S547-S554.
Crossref
Crossref
Shreyasi Chatterjee & Amritpal Mudher. (2018) Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits. Frontiers in Neuroscience 12.
Crossref
Crossref
Xue-Yang Jiang, Ting-Kai Chen, Jun-Ting Zhou, Si-Yu He, Hong-Yu Yang, Yao Chen, Wei Qu, Feng Feng & Hao-Peng Sun. (2018) Dual GSK-3β/AChE Inhibitors as a New Strategy for Multitargeting Anti-Alzheimer’s Disease Drug Discovery. ACS Medicinal Chemistry Letters 9:3, pages 171-176.
Crossref
Crossref
Steven E. Arnold, Zoe Arvanitakis, Shannon L. Macauley-Rambach, Aaron M. Koenig, Hoau-Yan Wang, Rexford S. Ahima, Suzanne Craft, Sam Gandy, Christoph Buettner, Luke E. Stoeckel, David M. Holtzman & David M. Nathan. (2018) Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums. Nature Reviews Neurology 14:3, pages 168-181.
Crossref
Crossref
Aaron M. Koenig, Zoe Arvanitakis & Steven E. Arnold. 2018. Type 2 Diabetes and Dementia. Type 2 Diabetes and Dementia
143
168
.
Wanyue Huang, Ping Cheng, Kaiyuan Yu, Yanfei Han, Miao Song & Yanfei Li. (2017) Hyperforin attenuates aluminum-induced Aβ production and Tau phosphorylation via regulating Akt/GSK-3β signaling pathway in PC12 cells. Biomedicine & Pharmacotherapy 96, pages 1-6.
Crossref
Crossref
Wei-Chun J. Hsu, Norelle C. Wildburger, Sigmund J. Haidacher, Miroslav N. Nenov, Oluwarotimi Folorunso, Aditya K. Singh, Brent C. Chesson, Whitney F. Franklin, Ibdanelo Cortez, Rovshan G. Sadygov, Kelly T. Dineley, Jay S. Rudra, Giulio Taglialatela, Cheryl F. Lichti, Larry Denner & Fernanda Laezza. (2017) PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease. Experimental Neurology 295, pages 1-17.
Crossref
Crossref
Eva Alonso, Andrés C. Vieira, Inés Rodriguez, Rebeca Alvariño, Sandra Gegunde, Haruhiko Fuwa, Yuto Suga, Makoto Sasaki, Amparo Alfonso, José Manuel Cifuentes & Luis M. Botana. (2017) Tetracyclic Truncated Analogue of the Marine Toxin Gambierol Modifies NMDA, Tau, and Amyloid β Expression in Mice Brains: Implications in AD Pathology. ACS Chemical Neuroscience 8:6, pages 1358-1367.
Crossref
Crossref
Rachel E. Lackie, Andrzej Maciejewski, Valeriy G. Ostapchenko, Jose Marques-Lopes, Wing-Yiu Choy, Martin L. Duennwald, Vania F. Prado & Marco A. M. Prado. (2017) The Hsp70/Hsp90 Chaperone Machinery in Neurodegenerative Diseases. Frontiers in Neuroscience 11.
Crossref
Crossref
Kongzhen Hu, Debasis Patnaik, Thomas Lee Collier, Katarzyna N. Lee, Han Gao, Matthew R. Swoyer, Benjamin H. Rotstein, Hema S. Krishnan, Steven H. Liang, Jin Wang, Zhiqiang Yan, Jacob M. Hooker, Neil Vasdev, Stephen J. Haggarty & Ming-Yu Ngai. (2017)
Development of [
18
F]Maleimide-Based Glycogen Synthase Kinase-3β Ligands for Positron Emission Tomography Imaging
. ACS Medicinal Chemistry Letters 8:3, pages 287-292.
Crossref
Crossref
Marta Pardo, Eleonore Beurel & Richard S. Jope. (2016) Cotinine administration improves impaired cognition in the mouse model of Fragile X syndrome. European Journal of Neuroscience 45:4, pages 490-498.
Crossref
Crossref
Avital Licht-MuravaRom PazLilach VaksLimor AvrahamiBatya PlotkinMiriam EisensteinHagit Eldar-Finkelman. (2016) A unique type of GSK-3 inhibitor brings new opportunities to the clinic. Science Signaling 9:454.
Crossref
Crossref
Andrew V. Mossine, Allen F. Brooks, Isaac M. Jackson, Carole A. Quesada, Phillip Sherman, Erin L. Cole, David J. Donnelly, Peter J. H. Scott & Xia Shao. (2016)
Synthesis of Diverse
11
C-Labeled PET Radiotracers via Direct Incorporation of [
11
C]CO
2
. Bioconjugate Chemistry 27:5, pages 1382-1389.
Crossref
Crossref
. 2016. Computational Systems Biology. Computational Systems Biology
145
160
.
Paola Lecca, Angela Re, Adaoha Ihekwaba, Ivan Mura & Thanh-Phuong Nguyen. 2016. Computational Systems Biology. Computational Systems Biology
119
140
.
Federica Prati, Angela De Simone, Andrea Armirotti, Maria Summa, Daniela Pizzirani, Rita Scarpelli, Sine Mandrup Bertozzi, Daniel I. Perez, Vincenza Andrisano, Ana Perez-Castillo, Barbara Monti, Francesca Massenzio, Letizia Polito, Marco Racchi, Piera Sabatino, Giovanni Bottegoni, Ana Martinez, Andrea Cavalli & Maria L. Bolognesi. (2015)
3,4-Dihydro-1,3,5-triazin-2(1
H
)-ones as the First Dual BACE-1/GSK-3β Fragment Hits against Alzheimer’s Disease
. ACS Chemical Neuroscience 6:10, pages 1665-1682.
Crossref
Crossref
Lei LiXia Shao, Erin L. Cole, Stephan A. OhnmachtValentina FerrariYoung T. HongDavid J. WilliamsonTim D. FryerCarole A. Quesada, Phillip Sherman, Patrick J. RissPeter J. H. Scott & Franklin I. Aigbirhio. (2015)
Synthesis and Initial
in Vivo
Studies with [
11
C]SB-216763: The First Radiolabeled Brain Penetrative Inhibitor of GSK-3
. ACS Medicinal Chemistry Letters 6:5, pages 548-552.
Crossref
Crossref
Eleonore Beurel, Steven F. Grieco & Richard S. Jope. (2015) Glycogen synthase kinase-3 (GSK3): Regulation, actions, and diseases. Pharmacology & Therapeutics 148, pages 114-131.
Crossref
Crossref
Marta Pardo, Margaret K. King, Emma Perez-Costas, Miguel Melendez-Ferro, Ana Martinez, Eleonore Beurel & Richard S. Jope. (2015) Impairments in cognition and neural precursor cell proliferation in mice expressing constitutively active glycogen synthase kinase-3. Frontiers in Behavioral Neuroscience 9.
Crossref
Crossref
Songhee Jeon, Jeong-Eun Park, Jinhee Lee, Quan Feng Liu, Ha Jin Jeong, Sok Cheon Pak, Sudok Yi, Myung Hun Kim, Chan-Wha Kim, Jung-Keug Park, Geun Woo Kim & Byung-Soo Koo. (2015) Illite improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer׳s disease through Akt/CREB and GSK-3β phosphorylation in the brain. Journal of Ethnopharmacology 160, pages 69-77.
Crossref
Crossref
Federica Prati, Angela De Simone, Paola Bisignano, Andrea Armirotti, Maria Summa, Daniela Pizzirani, Rita Scarpelli, Daniel I. Perez, Vincenza Andrisano, Ana Perez‐Castillo, Barbara Monti, Francesca Massenzio, Letizia Polito, Marco Racchi, Angelo D. Favia, Giovanni Bottegoni, Ana Martinez, Maria Laura Bolognesi & Andrea Cavalli. (2014) Multitarget Drug Discovery for Alzheimer's Disease: Triazinones as BACE‐1 and GSK‐3β Inhibitors. Angewandte Chemie International Edition 54:5, pages 1578-1582.
Crossref
Crossref
Federica Prati, Angela De Simone, Paola Bisignano, Andrea Armirotti, Maria Summa, Daniela Pizzirani, Rita Scarpelli, Daniel I. Perez, Vincenza Andrisano, Ana Perez‐Castillo, Barbara Monti, Francesca Massenzio, Letizia Polito, Marco Racchi, Angelo D. Favia, Giovanni Bottegoni, Ana Martinez, Maria Laura Bolognesi & Andrea Cavalli. (2014) Multitarget Drug Discovery for Alzheimer's Disease: Triazinones as BACE‐1 and GSK‐3β Inhibitors. Angewandte Chemie 127:5, pages 1598-1602.
Crossref
Crossref
Gemma McGregor, Yasaman Malekizadeh & Jenni Harvey. (2015) Minireview: Food for Thought: Regulation of Synaptic Function by Metabolic Hormones. Molecular Endocrinology 29:1, pages 3-13.
Crossref
Crossref
Enrique Blázquez, Esther Velázquez, Verónica Hurtado-Carneiro & Juan Miguel Ruiz-Albusac. (2014) Insulin in the Brain: Its Pathophysiological Implications for States Related with Central Insulin Resistance, Type 2 Diabetes and Alzheimer’s Disease. Frontiers in Endocrinology 5.
Crossref
Crossref
Georges Mairet-Coello & Franck Polleux. (2014) Involvement of ‘stress–response’ kinase pathways in Alzheimer's disease progression. Current Opinion in Neurobiology 27, pages 110-117.
Crossref
Crossref
Thanh-Phuong Nguyen, Laura Caberlotto, Melissa J. Morine & Corrado Priami. (2014) Network Analysis of Neurodegenerative Disease Highlights a Role of Toll-Like Receptor Signaling. BioMed Research International 2014, pages 1-16.
Crossref
Crossref
Laura Trujillo-Estrada, Sebastian Jimenez, Vanessa De Castro, Manuel Torres, David Baglietto-Vargas, Ines Moreno-Gonzalez, Victoria Navarro, Raquel Sanchez-Varo, Elisabeth Sanchez-Mejias, Jose Carlos Davila, Marisa Vizuete, Antonia Gutierrez & Javier Vitorica. (2013) In vivo modification of Abeta plaque toxicity as a novel neuroprotective lithium-mediated therapy for Alzheimer’s disease pathology. Acta Neuropathologica Communications 1:1.
Crossref
Crossref
Yuanhui Ma, Jintao Bao, Xuyang Zhao, Hongyan Shen, Junniao Lv, Shuaipeng Ma, Xuefei Zhang, Zeyang Li, Shuxin Wang, Qingsong Wang & Jianguo Ji. (2013) Activated Cyclin-Dependent Kinase 5 Promotes Microglial Phagocytosis of Fibrillar β-Amyloid by Up-regulating Lipoprotein Lipase Expression. Molecular & Cellular Proteomics 12:10, pages 2833-2844.
Crossref
Crossref
Mak Adam Daulatzai. (2013) Neurotoxic Saboteurs: Straws that Break the Hippo’s (Hippocampus) Back Drive Cognitive Impairment and Alzheimer’s Disease. Neurotoxicity Research 24:3, pages 407-459.
Crossref
Crossref
Juhwan Kim, Miyoung Yang, Sung-Ho Kim, Jong-Choon Kim, Hongbing Wang, Taekyun Shin & Changjong Moon. (2013) Possible Role of the Glycogen Synthase Kinase-3 Signaling Pathway in Trimethyltin-Induced Hippocampal Neurodegeneration in Mice. PLoS ONE 8:8, pages e70356.
Crossref
Crossref
Dongmei Wang, Xiaoying Li, Kai Gao, Dan Lu, Xu Zhang, Chunmei Ma, Fei Ye & Lianfeng Zhang. (2013) Cardiotrophin-1 (CTF1) ameliorates glucose-uptake defects and improves memory and learning deficits in a transgenic mouse model of Alzheimer's disease. Pharmacology Biochemistry and Behavior 107, pages 48-57.
Crossref
Crossref
Jim R. Fadel, Corinne G. Jolivalt & Lawrence P. Reagan. (2013) Food for thought: The role of appetitive peptides in age-related cognitive decline. Ageing Research Reviews 12:3, pages 764-776.
Crossref
Crossref
Rasoul Ghasemi, Leila Dargahi, Ali Haeri, Maryam Moosavi, Zahurin Mohamed & Abolhassan Ahmadiani. (2013) Brain Insulin Dysregulation: Implication for Neurological and Neuropsychiatric Disorders. Molecular Neurobiology 47:3, pages 1045-1065.
Crossref
Crossref
Yuan-Shih Hu, Nancy Long, Gustavo Pigino, Scott T. Brady & Orly Lazarov. (2013) Molecular Mechanisms of Environmental Enrichment: Impairments in Akt/GSK3β, Neurotrophin-3 and CREB Signaling. PLoS ONE 8:5, pages e64460.
Crossref
Crossref
Christoph Köhler, Maja Dinekov & Jürgen Götz. (2013) Active glycogen synthase kinase-3 and tau pathology-related tyrosine phosphorylation in pR5 human tau transgenic mice. Neurobiology of Aging 34:5, pages 1369-1379.
Crossref
Crossref
Misha Zilberter, Anton Ivanov, Sofya Ziyatdinova, Marat Mukhtarov, Anton Malkov, Alan Alpár, Giuseppe Tortoriello, Catherine H. Botting, Lívia Fülöp, Alex A. Osypov, Asla Pitkänen, Heikki Tanila, Tibor Harkany & Yuri Zilberter. (2013) Dietary energy substrates reverse early neuronal hyperactivity in a mouse model of Alzheimer's disease. Journal of Neurochemistry 125:1, pages 157-171.
Crossref
Crossref
Jing Shi, Jinzhou Tian, Xuekai Zhang, Chuiyou Zeng, Mingqing Wei, Pengwen Wang & Yongyan Wang. (2013) A combination extract of Renshen (Panax Ginseng), Yinyanghuo (Herba Epimedii Brevicornus), Yuanzhi (Radix Palygalae) and Jianghuang (Rhizoma Curcumae Longae) decreases glycogen synthase kinase 3β expression in brain cortex of APPV717I transgenic mice. Journal of Traditional Chinese Medicine 33:2, pages 211-217.
Crossref
Crossref
Celia López-Menéndez, Andrea Gamir-Morralla, Jerónimo Jurado-Arjona, Alonso M. Higuero, Miguel R. Campanero, Isidro Ferrer, Félix Hernández, Jesús Ávila, Margarita Díaz-Guerra & Teresa Iglesias. (2013) Kidins220 accumulates with tau in human Alzheimer's disease and related models: modulation of its calpain-processing by GSK3β/PP1 imbalance. Human Molecular Genetics 22:3, pages 466-482.
Crossref
Crossref
G. Joseph Broussard, Jennifer Mytar, Rung-chi Li & Gloria J. Klapstein. (2012) The role of inflammatory processes in Alzheimer’s disease. Inflammopharmacology 20:3, pages 109-126.
Crossref
Crossref
Aurelio Vazquez de la Torre, Felix Junyent, Jaume Folch, Carme Pelegrí, Jordi Vilaplana, Carme Auladell, Carlos Beas-Zarate, Mercè Pallàs, Ester Verdaguer & Antoni Camins. (2012) GSK3β inhibition is involved in the neuroprotective effects of cyclin-dependent kinase inhibitors in neurons. Pharmacological Research 65:1, pages 66-73.
Crossref
Crossref
Ravi S. Akundi, Lianteng Zhi & Hansruedi Büeler. (2012) PINK1 enhances insulin-like growth factor-1-dependent Akt signaling and protection against apoptosis. Neurobiology of Disease 45:1, pages 469-478.
Crossref
Crossref
Eun Ji Gong, Hee Ra Park, Mi Eun Kim, Shunfu Piao, Eunjin Lee, Dong-Gyu Jo, Hae Young Chung, Nam-Chul Ha, Mark P. Mattson & Jaewon Lee. (2011) Morin attenuates tau hyperphosphorylation by inhibiting GSK3β. Neurobiology of Disease 44:2, pages 223-230.
Crossref
Crossref
Jenna C. Carroll, Michiyo Iba, Debra A. Bangasser, Rita J. Valentino, Michael J. James, Kurt R. Brunden, Virginia M.-Y. Lee & John Q. Trojanowski. (2011) Chronic Stress Exacerbates Tau Pathology, Neurodegeneration, and Cognitive Performance through a Corticotropin-Releasing Factor Receptor-Dependent Mechanism in a Transgenic Mouse Model of Tauopathy. The Journal of Neuroscience 31:40, pages 14436-14449.
Crossref
Crossref
Fernando Kreutz, Rudimar L. Frozza, Ana Carolina Breier, Valeska A. de Oliveira, Ana Paula Horn, Letícia F. Pettenuzzo, Carlos Alexandre Netto, Christianne Gazzana Salbego & Vera Maria Treis Trindade. (2011) Amyloid-β induced toxicity involves ganglioside expression and is sensitive to GM1 neuroprotective action. Neurochemistry International 59:5, pages 648-655.
Crossref
Crossref
A. Johnston, K. Ponzetti, M. S. Anwer & C. R. L. Webster. (2011)
cAMP-guanine exchange factor protection from bile acid-induced hepatocyte apoptosis involves glycogen synthase kinase regulation of c-Jun NH
2
-terminal kinase
. American Journal of Physiology-Gastrointestinal and Liver Physiology 301:2, pages G385-G400.
Crossref
Crossref
Haiyan Lou, Peihong Fan, Ruth G. Perez & Hongxiang Lou. (2011) Neuroprotective effects of linarin through activation of the PI3K/Akt pathway in amyloid-β-induced neuronal cell death. Bioorganic & Medicinal Chemistry 19:13, pages 4021-4027.
Crossref
Crossref
DMITRY I. OSOLODKIN, NATALIA V. ZAKHAREVICH, VLADIMIR A. PALYULIN, VALERY N. DANILENKO & NIKOLAY S. ZEFIROV. (2011) Bioinformatic analysis of glycogen synthase kinase 3: human versus parasite kinases. Parasitology 138:6, pages 725-735.
Crossref
Crossref
Alejandro López-Tobón, John Fredy Castro-Álvarez, Diego Piedrahita, Ryan L. Boudreau, Juan Carlos Gallego-Gómez & Gloria Patricia Cardona-Gómez. (2011) Silencing of CDK5 as potential therapy for Alzheimer’s disease. revneuro 22:2, pages 143-152.
Crossref
Crossref
Pamela Salcedo-Tello, Abril Ortiz-Matamoros & Clorinda Arias. (2011) GSK3 Function in the Brain during Development, Neuronal Plasticity, and Neurodegeneration. International Journal of Alzheimer's Disease 2011, pages 1-12.
Crossref
Crossref
Jari Koistinaho, Tarja Malm & Gundars Goldsteins. (2011)
Glycogen Synthase Kinase-3
β
: A Mediator of Inflammation in Alzheimer's Disease?
. International Journal of Alzheimer's Disease 2011, pages 1-9.
Crossref
Crossref
Xiaochuan Wang, Julie Blanchard, Erik Kohlbrenner, Nathalie Clement, R Michael Linden, Aurelian Radu, Inge Grundke‐Iqbal & Khalid Iqbal. (2010) The carboxy‐terminal fragment of inhibitor‐2 of protein phosphatase‐2A induces Alzheimer disease pathology and cognitive impairment. The FASEB Journal 24:11, pages 4420-4432.
Crossref
Crossref